News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,370 Results
Type
Article (39629)
Company Profile (247)
Press Release (657494)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204139)
Career Advice (2008)
Deals (35415)
Drug Delivery (95)
Drug Development (81041)
Employer Resources (172)
FDA (16172)
Job Trends (14852)
News (345144)
Policy (32527)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49409)
ALS (86)
Alzheimer's disease (1369)
Antibody-drug conjugate (ADC) (112)
Approvals (16174)
Artificial intelligence (241)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (262)
Cancer (2083)
Cardiovascular disease (167)
Career advice (1675)
Career pathing (29)
CAR-T (143)
Cell therapy (403)
Cervical cancer (19)
Clinical research (65842)
Collaboration (794)
Compensation (508)
Complete response letters (19)
COVID-19 (2583)
CRISPR (37)
C-suite (223)
Cystic fibrosis (100)
Data (2051)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (256)
Diagnostics (6349)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86338)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (111894)
Executive appointments (693)
FDA (17357)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (719)
Gene editing (100)
Generative AI (19)
Gene therapy (285)
GLP-1 (697)
Government (4405)
Grass and pollen (4)
Guidances (51)
Healthcare (18812)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2723)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16494)
IRA (40)
Job creations (3630)
Job search strategy (1423)
Kidney cancer (9)
Labor market (36)
Layoffs (460)
Leadership (16)
Legal (7908)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (282)
MASH (62)
Medical device (13346)
Medtech (13351)
Mergers & acquisitions (19436)
Metabolic disorders (655)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (24)
Neuroscience (1874)
NextGen: Class of 2025 (6513)
Non-profit (4477)
Northern California (2533)
Now hiring (38)
Obesity (353)
Opinion (203)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57207)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20504)
Phase II (28992)
Phase III (21610)
Pipeline (1115)
Policy (130)
Postmarket research (2563)
Preclinical (8677)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (371)
Real estate (5907)
Recruiting (65)
Regulatory (22202)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (124)
Series B (82)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2179)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3573)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (28)
United States (21998)
Vaccines (668)
Venture capitalists (38)
Weight loss (229)
Women's health (34)
Worklife (15)
Date
Today (32)
Last 7 days (479)
Last 30 days (2363)
Last 365 days (32890)
2025 (9202)
2024 (35221)
2023 (40080)
2022 (51184)
2021 (55713)
2020 (54083)
2019 (46544)
2018 (35019)
2017 (32115)
2016 (31486)
2015 (37556)
2014 (31320)
2013 (26348)
2012 (28575)
2011 (29264)
2010 (27332)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37761)
Australia (6180)
California (5777)
Canada (1939)
China (489)
Colorado (253)
Connecticut (262)
Delaware (134)
Europe (81028)
Florida (860)
Georgia (203)
Idaho (57)
Illinois (513)
India (25)
Indiana (300)
Iowa (9)
Japan (149)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (856)
Massachusetts (4331)
Michigan (215)
Minnesota (378)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1659)
New Mexico (28)
New York (1650)
North Carolina (935)
North Dakota (7)
Northern California (2533)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1304)
Puerto Rico (11)
Rhode Island (30)
South America (1096)
South Carolina (20)
South Dakota (1)
Southern California (2179)
Tennessee (99)
Texas (860)
Utah (171)
Virginia (135)
Washington D.C. (59)
Washington State (530)
West Virginia (3)
Wisconsin (51)
697,370 Results for "apollo endosurgery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq: APEN) for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million.
November 29, 2022
·
8 min read
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
Press Releases
Topline Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in Patients with Early Alzheimer’s Disease Carrying Two Copies of APOE4 Gene
April 10, 2025
·
13 min read
Press Releases
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India
March 4, 2025
·
3 min read
Press Releases
Alzheon to Present Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 at Dedicated Symposium at ADPD Conference in Vienna on April 1st, 2025
March 18, 2025
·
10 min read
Business
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the third quarter ended September 30, 2022 and recent corporate highlights.
November 1, 2022
·
14 min read
Lone Star Bio
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
Apollo Endosurgery, Inc. announced today that the MERIT trial, published in The Lancet earlier this year (1), was selected as 2022 Top Story in Gastroenterology.
December 13, 2022
·
6 min read
Business
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.
August 2, 2022
·
13 min read
Business
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
Apollo Endosurgery, Inc. today announced that the Company is scheduled to release financial results for the third quarter ended September 30, 2022 on Tuesday, November 1, 2022, after market close.
October 18, 2022
·
2 min read
Deals
Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Apollo Medical Holdings, Inc. today announced that effective on January 23, 2024, the Compensation Committee of ApolloMed’s Board of Directors (the “Committee”) granted 85,130 shares of time-based restricted common stock and 65,265 shares of performance-based restricted common stock to Dinesh M. Kumar, M.D., the Company’s newly-hired Chief Medical Officer, under the Apollo Medical Holdings, Inc. Employment Inducement Award Plan (the “Inducement Plan”).
January 24, 2024
·
3 min read
1 of 69,737
Next
